Fludarabine plus rituximab for untreated B-cell chronic lymphocytic leukemia

Blood. 2003 Sep 15;102(6):2309; author reply 2309-10. doi: 10.1182/blood-2003-05-1443.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents / therapeutic use*
  • Drug Therapy, Combination
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell / drug therapy*
  • Rituximab
  • Vidarabine / analogs & derivatives*
  • Vidarabine / therapeutic use*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Antineoplastic Agents
  • Rituximab
  • Vidarabine
  • fludarabine